Generic Portal

— Research Explorer

Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study

Research output: Contribution to journal › Article › Academic › peer-review

Antineoplastic Combined Chemotherapy Protocols/adverse effects, Brentuximab Vedotin, Cisplatin, Cytarabine/therapeutic use, Dexamethasone/therapeutic use, Hodgkin Disease/drug therapy, Humans, Neoplasm Recurrence, Local, Positron Emission Tomography Computed Tomography, Recurrence, Salvage Therapy, Treatment Outcome

ID: 21354087